Galecto

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Galecto and other ETFs, options, and stocks.

About GLTO

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. 

CEO
Hans Thalsgård Schambye
CEOHans Thalsgård Schambye
Employees
5
Employees5
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2011
Founded2011
Employees
5
Employees5

GLTO Key Statistics

Market cap
3.54M
Market cap3.54M
Price-Earnings ratio
-0.14
Price-Earnings ratio-0.14
Dividend yield
—
Dividend yield—
Average volume
39.95K
Average volume39.95K
High today
$2.88
High today$2.88
Low today
$2.59
Low today$2.59
Open price
$2.85
Open price$2.85
Volume
158.91K
Volume158.91K
52 Week high
$18.50
52 Week high$18.50
52 Week low
$2.01
52 Week low$2.01
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.